Literature DB >> 15548474

Clear indications of emotion depend on vivid stimuli.

J Zihl.   

Abstract

Mesh：

Year:  2004        PMID： 15548474      PMCID： PMC1738840          DOI： 10.1136/jnnp.2004.048009

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  34 in total

1.  Psychiatric uses of antiepileptic treatments.

Authors:  Laura S. Boylan; Orrin Devinsky; John J. Barry; Terence A. Ketter
Journal:  Epilepsy Behav       Date:  2002-10       Impact factor: 2.937

2.  Psychopharmacology: atypical antipsychotic dosing: the effect of co-medication with anticonvulsants.

Authors:  Jose de Leon
Journal:  Psychiatr Serv       Date:  2004-02       Impact factor: 3.084

Review 3.  Antiepileptic drugs and reduced bone mineral density.

Authors:  Imran I Ali; Lori Schuh; Gregory L Barkley; John R Gates
Journal:  Epilepsy Behav       Date:  2004-06       Impact factor: 2.937

4.  Extrapyramidal syndrome due to valproate administration as an adjunct to lithium in an elderly manic patient.

Authors:  V Wils; G Golüke-Willemse
Journal:  Int J Geriatr Psychiatry       Date:  1997-02       Impact factor: 3.485

5.  Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.

Authors:  L J Stephen; P Kwan; D Shapiro; M Dominiczak; M J Brodie
Journal:  Epilepsia       Date:  2001-08       Impact factor: 5.864

6.  Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy.

Authors:  Martha J Morrell; Jouko Isojärvi; Ann E Taylor; Mogens Dam; Ricardo Ayala; Gema Gomez; Fiona O'Neill; Pat Tennis; John Messenheimer
Journal:  Epilepsy Res       Date:  2003-05       Impact factor: 3.045

7.  Valproate potentiates androgen biosynthesis in human ovarian theca cells.

Authors:  Velen L Nelson-DeGrave; Jessica K Wickenheisser; Jennifer E Cockrell; Jennifer R Wood; Richard S Legro; Jerome F Strauss; Jan M McAllister
Journal:  Endocrinology       Date:  2003-10-23       Impact factor: 4.736

8.  Psychiatric adverse events during levetiracetam therapy.

Authors:  M Mula; M R Trimble; A Yuen; R S N Liu; J W A S Sander
Journal:  Neurology       Date:  2003-09-09       Impact factor: 9.910

9.  Facial recognition deficits and cognition in schizophrenia.

Authors:  Gabriele Sachs; Dorothea Steger-Wuchse; Ilse Kryspin-Exner; Ruben C Gur; Heinz Katschnig
Journal:  Schizophr Res       Date:  2004-05-01       Impact factor: 4.939

10.  The influence of comorbid depression on quality of life for people with epilepsy.

Authors:  Joyce A Cramer; David Blum; Michael Reed; Kristina Fanning
Journal:  Epilepsy Behav       Date:  2003-10       Impact factor: 2.937
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.